has ongoing alliances and collaborations with partners that enable us to develop a broad line of field-proven products that enhance the welfare and performance of poultry, swine, and other farm animals.

AbCelex translate scientific discoveries from the lab bench to the field, by going through proof-of-concept field trials to find and advance the most promising product candidates. These proof-of-concept studies often focus on epidemic and endemic diseases of animal health.

AbCelex core proprietary technology Platform is a targeted protein feed additive approach that have demonstrated the potential to establish a new paradigm to prevent and treat a number of bacterial infections at source in livestock.

As a pre-revenue venture-funded start-up biotech company, it is the policy of AbCelex to pay up to 15% overhead or indirect costs on grants provided to universities in the U.S. and Canada.

AbCelex Policy on Indirect Costs Paid to Contract Research Organizations

As a pre-revenue venture-funded start-up biotech company, it is the policy of AbCelex to pay up to 15% overhead or indirect costs on grants provided to contract research organizations in the U.S. and Canada.